The Crofter: Sustainable Communications.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 80, doi. 10.56012/jbdc3343
- By:
- Publication type:
- Article
Works matching IS 20474806 AND DT 2025 AND VI 34 AND IP 1
Results: 24
1
2
Freelancing.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 78, doi. 10.56012/klbn4782
- By:
- Publication type:
- Article
3
Good Writing Practice.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 77, doi. 10.56012/scgm1052
- By:
- Publication type:
- Article
4
My First Medical Writing.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 74, doi. 10.56012/avjy7101
- By:
- Publication type:
- Article
5
Biotechnology.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 70, doi. 10.56012/dgla9046
- By:
- Publication type:
- Article
6
AI/Automation.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 67, doi. 10.56012/wxzm3433
- By:
- Publication type:
- Article
7
Medical Devices.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 66, doi. 10.56012/beyk2425
- By:
- Publication type:
- Article
8
News from the EMA.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 60
- By:
- Publication type:
- Article
9
An interview with Research Policy and Initiatives Director Roseline Favresse at the European Organisation for Rare Diseases.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 56, doi. 10.56012/cfip4618
- By:
- Publication type:
- Article
10
Penning hope: The impact of medical writing for rare conditions.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 52, doi. 10.56012/kppv3486
- By:
- Publication type:
- Article
11
On orphans and zebras.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 51
- By:
- Publication type:
- Article
12
How can real-world data, registries, and databases address the challenges of rare diseases?
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 46, doi. 10.56012/kwle5627
- By:
- Publication type:
- Article
13
Population diversity in clinical trials for rare diseases: A regulatory writer's perspective.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 42, doi. 10.56012/chhh9584
- By:
- Publication type:
- Article
14
Model-informed drug development in rare diseases An introduction for medical writers.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 36, doi. 10.56012/sbrq7799
- By:
- Publication type:
- Article
15
Innovative use of master protocols for pivotal studies in rare diseases.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 32, doi. 10.56012/lmmt8627
- By:
- Publication type:
- Article
16
Writing for orphan drugs: A compass to navigate document types and regional requirements.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 24, doi. 10.56012/suws8001
- By:
- Publication type:
- Article
17
Regulatory writing for rare disease: An interview with Kelley Hill.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 22, doi. 10.56012/gfym3039
- By:
- Publication type:
- Article
18
Essential investments in optimising clinical research for rare diseases.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 16, doi. 10.56012/rqli4755
- By:
- Publication type:
- Article
19
Living with a rare disease: A personal perspective.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 12, doi. 10.56012/otyj6941
- By:
- Publication type:
- Article
20
EMWA News.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 10, doi. 10.56012/vfnc6390
- By:
- Publication type:
- Article
21
President's Message Writing for rare diseases.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 8, doi. 10.56012/fblb6643
- By:
- Publication type:
- Article
22
From the Editor Rare experiences.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 6, doi. 10.56012/rkrh4645
- By:
- Publication type:
- Article
23
About Nora Patterson, our cover artist.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 5
- Publication type:
- Article
24
Rare diseases.
- Published in:
- Medical Writing, 2025, v. 34, n. 1, p. 2, doi. 10.56012/nvvg4559
- By:
- Publication type:
- Article